In this section, you can access to the latest technical information related to the FUTURE project topic.

A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital

Objectives Health care providers (HCP) are at high risk of acquiring and transmitting pertussis to susceptible family members, co-workers, and patients. Public health authorities recommend administering a single dose of Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccine to all adults, including HCP, to increase adult immunity to pertussis. We set a quality improvement goal to increase Tdap vaccination coverage among HCP who provided direct patient care at a children's hospital from 58% to 90% over 18?months.

» Author: Marc Fries, Paul Abell, Julie Brisset, Daniel Britt, Joshua Colwell, Adrienne Dove, Dan Durda, Lee Graham, Christine Hartzell, Kenneth Hrovat, Kristen John, Dakotah Karrer, Matthew Leonard, Stanley Love, Joseph Morgan, Jayme

» Reference: Vaccine, Volume 36, Issue 2

» Publication Date: 04/01/2018

» Source: ScienceDirect - GPP

« Go to Technological Watch



AIMPLAS Instituto Tecnológico del Plástico

C/ Gustave Eiffel, 4
(València Parc Tecnològic) - 46980
PATERNA (Valencia) - SPAIN

PHONE

(+34) 96 136 60 40

EMAIL

Project Management department - Sustainability and Industrial Recovery
life-future-project@aimplas.es